Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|March 27, 2026
Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib TreatmentElisa Minaldi, Teresa Ramone, Raffaele Ciampi, et al.
Nature Reviews. Endocrinology|July 15, 2017
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapiesEleonora Molinaro, Cristina Romei, Agnese Biagini, et al.
BMC Cancer|March 18, 2016
Runs of homozygosity and inbreeding in thyroid cancerHauke Thomsen, Bowang Chen, Gisella Figlioli, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2020
Polymorphisms Within the RET Proto-Oncogene and Risk of Sporadic Medullary Thyroid CarcinomaFederica Gemignani, Cristina Romei, Raffaele Ciampi, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2004
All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genesRossella Elisei, Agnese Vivaldi, Laura Agate, et al.
International Journal of Cancer|June 12, 2013
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populationsMonica Cipollini, Susana Pastor, Federica Gemignani, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2007
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up studyRossella Elisei, Barbara Cosci, Cristina Romei, et al.
Cancers|January 5, 2021
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid CarcinomaAntonio Matrone, Carla Gambale, Alessandro Prete, et al.
Archives of Toxicology|January 20, 2016
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinomaLucia Pellé, Monica Cipollini, Roman Tremmel, et al.
European Journal of Endocrinology|December 24, 2010
CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinomaDaniela Pasquali, Luisa Circelli, Antongiulio Faggiano, et al.
Pageof 11